These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8015078)

  • 1. Does of stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?
    Thrasher JB; Frazier HA; Robertson JE; Paulson DF
    J Urol; 1994 Aug; 152(2 Pt 1):393-6. PubMed ID: 8015078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer specific outcomes in patients with pT0 disease following radical cystectomy.
    Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Lotan Y; Vazina A; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP;
    J Urol; 2006 May; 175(5):1645-9; discussion 1649. PubMed ID: 16600721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final Pathological Stage after Neoadjuvant Chemotherapy and Radical Cystectomy for Bladder Cancer-Does pT0 Predict Better Survival than pTa/Tis/T1?
    Zargar H; Zargar-Shoshtari K; Lotan Y; Shah JB; van Rhijn BW; Daneshmand S; Spiess PE; Black P;
    J Urol; 2016 Apr; 195(4 Pt 1):886-93. PubMed ID: 26521718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic significance of pathologic stage T0 on organ-confined bladder transitional cell carcinoma following radical cystectomy.
    Cho KS; Seo JW; Park SY; Cho NH; Choi YD; Yang SC; Hong SJ
    Urol Int; 2008; 81(4):394-8. PubMed ID: 19077398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
    Tilki D; Svatek RS; Novara G; Seitz M; Godoy G; Karakiewicz PI; Kassouf W; Fradet Y; Fritsche HM; Sonpavde G; Izawa JI; Ficarra V; Lerner SP; Schoenberg M; Stief CG; Dinney CP; Skinner E; Lotan Y; Sagalowsky AI; Reich O; Shariat SF
    J Urol; 2010 Sep; 184(3):888-94. PubMed ID: 20643448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with stage pT0/pT1/pTa in the radical cystectomy specimen.
    Husillos-Alonso A; Herranz Amo F; Subirá-Ríos D; Díez-Cordero JM; Moralejo-Gárate M; López-López E; Piñero-Sánchez J; Ogaya Pinies G; Lledó-García E; Hernández-Fernández C
    Arch Esp Urol; 2013 Oct; 66(8):787-95. PubMed ID: 24136482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].
    Escudero Barrilero A; Fernández Fernández E; Jiménez Cidre M; Maganto Pavón E; Mayayo Dehesa T; Rodríguez Rodríguez R; Galvis San Juan F; Burgos Revilla FJ
    Arch Esp Urol; 1996 May; 49(4):349-64. PubMed ID: 8754191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
    May M; Bastian PJ; Burger M; Bolenz C; Trojan L; Herrmann E; Wülfing C; Müller SC; Ellinger J; Buchner A; Stief CG; Tilki D; Otto W; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Wieland WF; Fritsche HM
    BJU Int; 2011 Oct; 108(8 Pt 2):E278-83. PubMed ID: 21699644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder.
    Amling CL; Thrasher JB; Frazier HA; Dodge RK; Robertson JE; Paulson DF
    J Urol; 1994 Jan; 151(1):31-5; discussion 35-6. PubMed ID: 8254828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downstaging and survival benefits of neoadjuvant radiotherapy before cystectomy for patients with invasive bladder carcinoma.
    Granfors T; Tomic R; Ljungberg B
    Scand J Urol Nephrol; 2009; 43(4):293-9. PubMed ID: 19363744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
    May M; Helke C; Nitzke T; Vogler H; Hoschke B
    Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of evolution of patients after pT0 radical cystectomy due to bladder cancer.
    Mediavilla E; Portillo JA; Truán D; Campos-Juanatey F; Gala L; Fuentes J; Carrión C; Gutiérrez JL
    Arch Esp Urol; 2014 Nov; 67(9):764-9. PubMed ID: 25407150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.
    Tollefson MK; Boorjian SA; Farmer SA; Frank I
    World J Urol; 2012 Dec; 30(6):795-9. PubMed ID: 22447397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative study.
    Rouprêt M; Drouin SJ; Larré S; Neuzillet Y; Botto H; Hitier M; Rigaud J; Crew J; Xylinas E; Salomon L; Cornu JN; Iborra F; Champetier D; Rozet F; Flamand V; Bastide C; Cormier L; Durand X; Lunardi P; Rischmann P; Nouhaud FX; Ferlicot S; Patard JJ; Floch AP; Irani J; Peyronnet B; Bensalah K; Poissonnier L; Grès P; Droupy S; Casenave J; Wallerand H; Soulié M; Pfister C;
    Ann Surg Oncol; 2011 Dec; 18(13):3833-8. PubMed ID: 21647762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: factors resulting in pT0 radical cystectomy specimens.
    Mazaris E; Nafie S; Boustead G
    Int Braz J Urol; 2013; 39(3):364-70. PubMed ID: 23849584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant cisplatin chemotherapy before radical cystectomy in invasive transitional cell carcinoma of the bladder: a prospective randomized phase III study.
    Martinez-Piñeiro JA; Gonzalez Martin M; Arocena F; Flores N; Roncero CR; Portillo JA; Escudero A; Jimenez Cruz F; Isorna S
    J Urol; 1995 Mar; 153(3 Pt 2):964-73. PubMed ID: 7853584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a second transurethral resection on the staging of T1 bladder cancer.
    Dalbagni G; Herr HW; Reuter VE
    Urology; 2002 Nov; 60(5):822-4; discussion 824-5. PubMed ID: 12429307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Tumor on Repeat Transurethral Resection of Bladder Tumor Does Not Predict Final Pathologic T0 Stage in Bladder Cancer Treated with Radical Cystectomy.
    Kukreja JB; Porten S; Golla V; Ho PL; Noguera-Gonzalez G; Navai N; Kamat AM; Dinney CPN; Shah JB
    Eur Urol Focus; 2018 Sep; 4(5):720-724. PubMed ID: 28753837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radical cystectomy in the treatment of cancer of the bladder].
    Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bielsa Carrillo A; García Burgos J; Subirá Ríos D; Castaño González I
    Arch Esp Urol; 2000 Sep; 53(7):619-24. PubMed ID: 11037655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.